echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > An enzyme that fights off viruses may also accelerate cancer evolution

    An enzyme that fights off viruses may also accelerate cancer evolution

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit


    Faltas and his team obtained a three-dimensional image of the nucleus of a cancer cell showing the APOBEC3G protein (green) within the nucleus (blue).

    A study led by researchers at Weill Cornell Medical College has shown that an enzyme that protects human cells from viruses can help propel cancer toward more serious malignancy by causing countless mutations in cancer cells
    This finding suggests that this enzyme could be a potential target for
    future cancer treatments.

    In the new study, published Dec.
    8 in Cancer Research, scientists used a preclinical model of bladder cancer to study the role of an enzyme called APOBEC3G in promoting disease progression and found that it significantly increased the number of mutations in tumor cells, increased the genetic diversity of bladder cancer, and accelerated mortality

    "Our findings suggest that APOBEC3G is an important factor in the evolution of bladder cancer and should be considered a target for future therapeutic strategies," said Bishoy M.
    Faltas, Ph.
    , senior author of the study, assistant professor of cell and developmental biology at Weill Cornell Medicine and an oncologist
    at New York-Presbyterian/Weill Cornell Medical Center specializing in urothelial cancer.

    The APOBEC3 family of enzymes is able to mutate RNA or DNA
    by chemically modifying cytosine nucleotides (the letter "C" in the genetic code).
    This can lead to the production of erroneous nucleotides
    at that location.
    The normal role of these enzymes, including APOBEC3G, is to fight retroviruses like HIV — which try to impede the replication of viruses by mutating cytosines in the viral genome

    The inherent dangers of these enzymes suggest that there must be some mechanism to prevent them from harming cellular DNA
    However, starting about a decade ago, researchers using new DNA sequencing techniques began to find widespread APOBEC3G-type mutations
    in cellular DNA in the context of cancer.
    In a 2016 study of human bladder tumor samples, Dr.
    Faltas, who is also director of bladder cancer research at the Institute for Precision Medicine England and a member of the Sandra and Edward Mayer Cancer Centre, found that a large proportion of mutations in these tumors were associated with APOBEC3G, and that these mutations appeared to play a role
    in helping tumors evade the effects of chemotherapy.

    These findings point to the possibility
    that cancers often use APOBEC3s to mutate their genomes.
    This not only helps them acquire all the mutations they need for cancer to grow, but also enhances their ability to diversify and "evolve" — allowing them to grow and spread
    further in the face of immune defenses, drug treatments, and other adverse factors.

    In the new study, Dr.
    Faltas and his team, including first author Weisi Liu, PhD, postdoctoral research assistant, addressed the specific role
    of APOBEC3G in bladder cancer through direct causal experiments.

    APOBEC3G is a human enzyme that mice do not have, so the team knocked out the only APOBEC3G enzyme gene in mice and replaced it with a gene for human APOBEC3G
    The researchers observed that when these APOBEC3G mice were exposed to a bladder cancer-promoting chemical that mimicked a carcinogen in cigarette smoke, they were more likely to develop this form of cancer (76 percent developed cancer), compared to mice whose APOBEC3G gene was knocked out and not replaced (53 percent developed cancer
    In addition, all of the knockout mice survived during the 30-week observation period, while nearly one-third of the APOBEC3G mice died of cancer

    To their surprise, the researchers found that APOBEC3G in mouse cells was present in the nucleus, which used "light sectioning" microscopy techniques to preserve cellular DNA
    Previously, this protein was thought to exist only outside
    the nucleus.
    They also found that APOBEC3G mice had twice as many bladder tumors as tumors in pure knockout mice

    By identifying specific mutational signatures of APOBEC3G and mapping them into the tumor genome, the team found ample evidence that the enzyme creates greater mutational burden and genomic diversity in tumors, which may be responsible for
    higher malignancy and mortality in APOBEC3G mice.
    "We found clear mutational features caused by APOBEC3G in these tumors, which are different
    from those caused by other members of the APOBEC3 family," said Dr.

    Finally, the researchers looked for mutation signatures for APOBEC3G in the Cancer Genome Atlas, a widely used database of human tumor DNA, and found that these mutations appeared to be common in bladder cancer and were associated with
    worse outcomes.

    "These findings will inform
    future efforts to limit or guide tumor evolution by targeting the APOBEC3 enzyme with drugs," said Dr.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.